/
Analyses & Displays for Hepatotoxicity

Analyses & Displays for Hepatotoxicity

Owned by Former user (Deleted)
Last updated: Dec 18, 2024 by Nicola Newton

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global

CURRENT STATUS Q4 2024

  • Finalise Stage 1 white paper following public review.
  • Get Stage 2 white paper ready for public review.

Objectives & Deliverables

Timelines 

Finalise Stage 1 of draft White Paper

Q4 2023

Related content

Working Group Report – Q4 2024
Working Group Report – Q4 2024
WORKING GROUPS
More like this
Safety Analytics Education
Safety Analytics Education
WORKING GROUPS
Read with this
Overall Safety Assessment – Standard Safety Tables and Figures
Overall Safety Assessment – Standard Safety Tables and Figures
WORKING GROUPS
More like this
Interactive Analyses and Displays for Laboratory Data
Interactive Analyses and Displays for Laboratory Data
WORKING GROUPS
Read with this
Safety Analytics Webinar Series: Overall Safety Assessment – Interactive Safety Graphics for Regulatory Decision-Making
Safety Analytics Webinar Series: Overall Safety Assessment – Interactive Safety Graphics for Regulatory Decision-Making
WORKING GROUPS
More like this
Safety Analytics
Safety Analytics
WORKING GROUPS
Read with this